Development and validation of point-of-care testing of albuminuria for early screening of chronic kidney disease

用于慢性肾脏病早期筛查的白蛋白尿即时检测方法的开发和验证

阅读:10
作者:Nuntanuj Vutthikraivit, Patcharakorn Kiatamornrak, Chatikorn Boonkrai, Trairak Pisitkun, Kittinan Komolpis, Songchan Puthong, Nuttha Lumlertgul, Sadudee Peerapornratana, Chusak Thanawattano, Somkanya Tungsanga, Kearkiat Praditpornsilpa, Kriang Tungsanga, Somchai Eiam-Ong, Nattachai Srisawat4

Conclusion

CU microalbumin correlated well with the standard method for quantitative measurement of urine albumin. Therefore, it has the potential for early screening of CKD, especially in primary health care facilities in resource limited settings.

Methods

The prototype strip test was developed under the concept of competitive lateral flow immunochromatography assay, or strip test. Monoclonal antibodies (MAbs) to human serum albumin (HSA) were harvested from the hybridomas of spleen cells from immunized mice and mouse myeloma cells. Presence of MAbs was detected by enzyme-linked immunosorbent assay (ELISA). Spot urine was obtained from patients with kidney disease, type I, or type II Diabetes Mellitus upon their visit at King Chulalongkorn Memorial Hospital during 2018-2019. All samples were analyzed for urine albumin with our POCT (CU microalbumin) and the other two commercial POCTs (Microalbu PHAN and MICRAL). The

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。